Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8-triazaspiro[4.5]decan-4-ones as potential antipsychotic agents
Authors:
- Lawrence D. WiseLWLawrence D. Wise
- Ian C. PattisonIPIan C. Pattison
- Donald E. ButlerDBDonald E. Butler
- Horace A. DeWaldHDHorace A. DeWald
- Edward P. LewisELEdward P. Lewis
- Sandra J. LobbestaelSLSandra J. Lobbestael
- Haile TecleHTHaile Tecle
- Linda L. CoughenourLCLinda L. Coughenour
- David A. DownsDDDavid A. Downs
- B. P. H. PoschelBPB. P. H. Poschel
- 1 December 1985
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 28 (12) , 1811-1817
Abstract
8-[3-[Bis(4-fluorophenyl)amino]propyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one (3) and related compounds have been shown to have antipsychotic profiles in biochemical and behavioral pharmacological test models. The dose of 3 necessary to produce catalepsy in rats is much greater than that required for activity in behavioral tests predictive of antipsychotic efficacy, for example the suppression of high base line medial forebrain bundle self-stimulation in rats. This suggests that 3 would have a reduced propensity for neurological side effects. The effects of substitution on the 1-phenyl moiety and on the N-3 nitrogen atom of the triazaspirodecanone portion of 3 were examined. Results from this study suggest that behavioral activity is sensitive to substituents on the 1-phenyl moiety while substituents on the N-3 nitrogen are more generally tolerated. In both rats and squirrel monkeys compound 3 was found to have a similar separation between doses inhibiting Sidman avoidance activity and those causing catalepsy. However, in an extrapyramidal side effect (EPS) test model using haloperidol-sensitized cebus monkeys, 3 elicited signs of EPS at doses approximating those previously determined to be efficacious.Keywords
This publication has 7 references indexed in Scilit:
- 1-[3-(Diarylamino)propyl]piperidines and Related Compounds, Potential Antipsychotic Agents with Low Cataleptogenic ProfilesJournal of Medicinal Chemistry, 1985
- Analysis of regional variations in the affinities of muscarinic agonists in the rat brainBrain Research, 1980
- Multiple Apparent Alpha-Noradrenergic Receptor Binding Sites in Rat Brain: Effect of 6-HydroxydopamineMolecular Pharmacology, 1979
- DEVELOPMENT OF ACUTE DYSTONIA AND TARDIVE-DYSKINESIA IN CEBUS MONKEYS1979
- A new device for the rapid measurement of impaired motor function in micePharmacology Biochemistry and Behavior, 1977
- Properties of [3H]Haloperidol and [3H]Dopamine Binding Associated with Dopamine Receptors in Calf Brain MembranesMolecular Pharmacology, 1976
- Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain.Journal of Comparative and Physiological Psychology, 1954